US4703008A
(en)
|
1983-12-13 |
1987-10-27 |
Kiren-Amgen, Inc. |
DNA sequences encoding erythropoietin
|
KR850004274A
(ko)
|
1983-12-13 |
1985-07-11 |
원본미기재 |
에리트로포이에틴의 제조방법
|
NZ210501A
(en)
|
1983-12-13 |
1991-08-27 |
Kirin Amgen Inc |
Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence
|
US5856298A
(en)
|
1989-10-13 |
1999-01-05 |
Amgen Inc. |
Erythropoietin isoforms
|
US7217689B1
(en)
|
1989-10-13 |
2007-05-15 |
Amgen Inc. |
Glycosylation analogs of erythropoietin
|
KR100263845B1
(ko)
|
1989-10-13 |
2000-08-16 |
스튜어트 엘.왓트 |
에리트로포이에틴 동형체와 그의 제조방법 및 그를 포함하는제약학적 조성물
|
US5353691A
(en)
*
|
1993-04-14 |
1994-10-11 |
Habley Medical Technology Corp. |
Self-lubricating piston for pharmaceutical container
|
ZA946122B
(en)
|
1993-08-17 |
1995-03-20 |
Amgen Inc |
Erythropoietin analogs
|
US6562596B1
(en)
|
1993-10-06 |
2003-05-13 |
Amgen Inc. |
Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods
|
US5773569A
(en)
|
1993-11-19 |
1998-06-30 |
Affymax Technologies N.V. |
Compounds and peptides that bind to the erythropoietin receptor
|
US5830851A
(en)
|
1993-11-19 |
1998-11-03 |
Affymax Technologies N.V. |
Methods of administering peptides that bind to the erythropoietin receptor
|
US5885574A
(en)
|
1994-07-26 |
1999-03-23 |
Amgen Inc. |
Antibodies which activate an erythropoietin receptor
|
CA2195557C
(fr)
|
1994-08-12 |
2006-10-17 |
Shui-On Leung |
Immunoconjugues et anticorps de type humain specifiques contre des lymphomes malins a cellules b et des cellules leucemiques
|
US5686292A
(en)
|
1995-06-02 |
1997-11-11 |
Genentech, Inc. |
Hepatocyte growth factor receptor antagonist antibodies and uses thereof
|
US5767078A
(en)
|
1995-06-07 |
1998-06-16 |
Johnson; Dana L. |
Agonist peptide dimers
|
US6053895A
(en)
*
|
1996-11-05 |
2000-04-25 |
Schering Aktiengesellschaft |
Syringe with a new and improved plug
|
US6753165B1
(en)
|
1999-01-14 |
2004-06-22 |
Bolder Biotechnology, Inc. |
Methods for making proteins containing free cysteine residues
|
EP1012184B1
(fr)
|
1997-07-14 |
2007-10-10 |
Bolder Biotechnology, Inc. |
Derives d'hormone de croissance et proteines associees
|
US6391633B1
(en)
|
1997-07-23 |
2002-05-21 |
Roche Diagnostics Gmbh |
Production of erythropoietin by endogenous gene activation
|
US6030086A
(en)
|
1998-03-02 |
2000-02-29 |
Becton, Dickinson And Company |
Flash tube reflector with arc guide
|
US6310078B1
(en)
|
1998-04-20 |
2001-10-30 |
Ortho-Mcneil Pharmaceutical, Inc. |
Substituted amino acids as erythropoietin mimetics
|
US20050181482A1
(en)
|
2004-02-12 |
2005-08-18 |
Meade Harry M. |
Method for the production of an erythropoietin analog-human IgG fusion proteins in transgenic mammal milk
|
EP1088084B1
(fr)
|
1998-06-15 |
2006-09-13 |
GTC Biotherapeutics, Inc. |
Proteine de fusion de l'erythropoietine analogue-albumine serique humaine
|
TWI257394B
(en)
|
1998-10-23 |
2006-07-01 |
Kirin Amgen Inc |
Thrombopoietic compounds
|
SI1813624T1
(sl)
|
1998-10-23 |
2010-12-31 |
Amgen Inc |
Postopki in sestavki za prepeäśevanje in zdravljenje anemije
|
CN101469329B
(zh)
|
1998-11-27 |
2012-10-24 |
达尔文发现有限公司 |
增加骨矿化的组合物和方法
|
EP1006184A1
(fr)
|
1998-12-03 |
2000-06-07 |
F. Hoffmann-La Roche Ag |
Protéines interagissant avec le récepteur de IGF-1, gènes codant pour ces protéines et leurs utilisations
|
JP2002544123A
(ja)
|
1999-04-14 |
2002-12-24 |
スミスクライン・ビーチャム・コーポレイション |
エリトロポイエチン受容体抗体
|
US7297680B2
(en)
|
1999-04-15 |
2007-11-20 |
Crucell Holland B.V. |
Compositions of erythropoietin isoforms comprising Lewis-X structures and high sialic acid content
|
CZ299516B6
(cs)
|
1999-07-02 |
2008-08-20 |
F. Hoffmann-La Roche Ag |
Konjugát erythropoetinového glykoproteinu, zpusobjeho výroby a použití a farmaceutická kompozice sjeho obsahem
|
JP2003512840A
(ja)
|
1999-10-22 |
2003-04-08 |
ミレニアム・ファーマシューティカルズ・インコーポレイテッド |
ラット脳に由来する核酸分子およびプログラム細胞死モデル
|
US20050202538A1
(en)
|
1999-11-12 |
2005-09-15 |
Merck Patent Gmbh |
Fc-erythropoietin fusion protein with improved pharmacokinetics
|
JP2003514552A
(ja)
|
1999-11-12 |
2003-04-22 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング |
改善された性質を有するエリトロポエチンの形態
|
US7223593B2
(en)
|
2000-01-21 |
2007-05-29 |
Biovex Limited |
Herpes virus strains for gene therapy
|
AUPQ599700A0
(en)
|
2000-03-03 |
2000-03-23 |
Super Internet Site System Pty Ltd |
On-line geographical directory
|
US6586398B1
(en)
|
2000-04-07 |
2003-07-01 |
Amgen, Inc. |
Chemically modified novel erythropoietin stimulating protein compositions and methods
|
JP5022551B2
(ja)
|
2000-04-21 |
2012-09-12 |
アムジエン・インコーポレーテツド |
貧血の予防及び治療用の方法及び組成物
|
US6756480B2
(en)
|
2000-04-27 |
2004-06-29 |
Amgen Inc. |
Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
|
US7078376B1
(en)
|
2000-08-11 |
2006-07-18 |
Baxter Healthcare S.A. |
Therapeutic methods for treating subjects with a recombinant erythropoietin having high activity and reduced side effects
|
CN1454097A
(zh)
|
2000-09-08 |
2003-11-05 |
格莱风治疗公司 |
聚合物修饰的合成的蛋白质类
|
US7271689B1
(en)
|
2000-11-22 |
2007-09-18 |
Fonar Corporation |
Magnet structure
|
DE60144439D1
(de)
|
2000-12-20 |
2011-05-26 |
Hoffmann La Roche |
Konjugate von erythropoietin (epo) mit polyethylenglykol (peg)
|
DZ3494A1
(fr)
|
2001-01-05 |
2002-07-11 |
Pfizer |
Anticorps anti-recepteur du facteur de croissance i analogue a l'insuline
|
JP2005503127A
(ja)
|
2001-04-04 |
2005-02-03 |
ジェンオディセ |
エリスロポエチン遺伝子の新規ポリヌクレオチド及びポリペプチド
|
RS51708B
(sr)
|
2001-05-11 |
2011-10-31 |
Amgen Inc. |
Peptidi i njima srodni molekuli koji se vezuju za tall-1
|
NZ530765A
(en)
|
2001-06-26 |
2006-11-30 |
Amgen Fremont Inc |
Antibodies that bind OPGL and compositions and methods for the treatment of bone diseases
|
US6900292B2
(en)
|
2001-08-17 |
2005-05-31 |
Lee-Hwei K. Sun |
Fc fusion proteins of human erythropoietin with increased biological activities
|
RS51829B
(sr)
|
2001-08-23 |
2012-02-29 |
Genmab A/S. |
Ljudska antitela specifična za interleukin 15 (il-15)
|
US7247304B2
(en)
|
2001-08-23 |
2007-07-24 |
Genmab A/S |
Methods of treating using anti-IL-15 antibodies
|
US6930086B2
(en)
|
2001-09-25 |
2005-08-16 |
Hoffmann-La Roche Inc. |
Diglycosylated erythropoietin
|
US7214660B2
(en)
|
2001-10-10 |
2007-05-08 |
Neose Technologies, Inc. |
Erythropoietin: remodeling and glycoconjugation of erythropoietin
|
US7521053B2
(en)
|
2001-10-11 |
2009-04-21 |
Amgen Inc. |
Angiopoietin-2 specific binding agents
|
US7138370B2
(en)
|
2001-10-11 |
2006-11-21 |
Amgen Inc. |
Specific binding agents of human angiopoietin-2
|
WO2003055526A2
(fr)
|
2001-12-21 |
2003-07-10 |
Maxygen Aps |
Conjugues d'erythropoietine
|
DK1461359T3
(da)
|
2002-01-18 |
2007-07-09 |
Pf Medicament |
Hidtil ukendte anti-IGF-IR-antistoffer og anvendelser deraf
|
US7241444B2
(en)
|
2002-01-18 |
2007-07-10 |
Pierre Fabre Medicament |
Anti-IGF-IR antibodies and uses thereof
|
EP1470232A1
(fr)
|
2002-01-31 |
2004-10-27 |
Oxford Biomedica (UK) Limited |
Vecteur d'expression de l'erythropoietine physiologiquement regule, destine au traitement de l'anemie
|
GB0202252D0
(en)
|
2002-01-31 |
2002-03-20 |
Oxford Biomedica Ltd |
Anemia
|
WO2003080852A1
(fr)
|
2002-03-26 |
2003-10-02 |
Lek Pharmaceutical And Chemical Company D.D. |
Procede de preparation du profil de glyco-isoformesd'erythropoietine recherche
|
DE60328092D1
(de)
|
2002-03-29 |
2009-08-06 |
Kumiai Chemical Industry Co |
Acetolactatsynthase codierende gene
|
WO2003084477A2
(fr)
|
2002-03-29 |
2003-10-16 |
Centocor, Inc. |
Corps mimetiques de cdr de mammifere, compositions, procedes et utilisations
|
US20050256035A1
(en)
|
2002-05-13 |
2005-11-17 |
Irving Boime |
Ctp-extended erythropoietin
|
US7217796B2
(en)
|
2002-05-24 |
2007-05-15 |
Schering Corporation |
Neutralizing human anti-IGFR antibody
|
US7538195B2
(en)
|
2002-06-14 |
2009-05-26 |
Immunogen Inc. |
Anti-IGF-I receptor antibody
|
US8034904B2
(en)
|
2002-06-14 |
2011-10-11 |
Immunogen Inc. |
Anti-IGF-I receptor antibody
|
EP1575499A2
(fr)
|
2002-06-28 |
2005-09-21 |
Centocor, Inc. |
Corps mimetiques d'epo de mammifere a deletion ch1, compositions, methodes et utilisations associees
|
JP2006504406A
(ja)
|
2002-06-28 |
2006-02-09 |
セントカー・インコーポレーテツド |
哺乳動物のch1欠失ミメティボディ、組成物、方法および使用
|
WO2004009627A1
(fr)
|
2002-07-19 |
2004-01-29 |
Cangene Corporation |
Composes erythropoietiques pegyles
|
JP4406607B2
(ja)
|
2002-08-26 |
2010-02-03 |
オンコセラピー・サイエンス株式会社 |
ペプチド及びこれを含む医薬
|
MXPA05002514A
(es)
|
2002-09-06 |
2005-05-27 |
Amgen Inc |
Anticuerpo monoclonal anti-il-1r1 humano terapeutico.
|
KR101045422B1
(ko)
|
2002-09-11 |
2011-06-30 |
프레제니우스 카비 도이치란트 게엠베하 |
하이드록시알킬 전분 유도체의 제조 방법
|
US6919426B2
(en)
|
2002-09-19 |
2005-07-19 |
Amgen Inc. |
Peptides and related molecules that modulate nerve growth factor activity
|
TWI320716B
(en)
|
2002-10-14 |
2010-02-21 |
Abbott Lab |
Erythropoietin receptor binding antibodies
|
US7396913B2
(en)
|
2002-10-14 |
2008-07-08 |
Abbott Laboratories |
Erythropoietin receptor binding antibodies
|
US20040071694A1
(en)
|
2002-10-14 |
2004-04-15 |
Devries Peter J. |
Erythropoietin receptor binding antibodies
|
AU2003285874A1
(en)
|
2002-10-16 |
2004-05-04 |
Amgen Inc. |
HUMAN ANTI-IFN-Gamma NEUTRALIZING ANTIBODIES AS SELECTIVE IFN-Gamma PATHWAY INHIBITORS
|
US20040091961A1
(en)
|
2002-11-08 |
2004-05-13 |
Evans Glen A. |
Enhanced variants of erythropoietin and methods of use
|
KR101304718B1
(ko)
|
2002-12-20 |
2013-09-05 |
암겐 인코포레이티드 |
미오스타틴을 저해하는 결합제
|
JP2007528201A
(ja)
|
2003-03-14 |
2007-10-11 |
ファルマシア・コーポレーション |
癌治療のためのigf−i受容体に対する抗体
|
WO2004087756A2
(fr)
|
2003-04-02 |
2004-10-14 |
F. Hoffmann-La Roche Ag |
Anticorps contre le recepteur du facteur de croissance 1 analogue a l'insuline et utilisations de ceux-ci
|
US7220410B2
(en)
|
2003-04-18 |
2007-05-22 |
Galaxy Biotech, Llc |
Monoclonal antibodies to hepatocyte growth factor
|
ES2527871T3
(es)
|
2003-05-01 |
2015-02-02 |
Imclone Llc |
Anticuerpos completamente humanos dirigidos contra el receptor del factor de crecimiento 1 similar a la insulina humana
|
TWI353991B
(en)
|
2003-05-06 |
2011-12-11 |
Syntonix Pharmaceuticals Inc |
Immunoglobulin chimeric monomer-dimer hybrids
|
ES2323465T3
(es)
|
2003-05-12 |
2009-07-16 |
Affymax, Inc. |
Peptidos novedosos que se unen al receptor de la eritropoyetina.
|
ES2395413T3
(es)
|
2003-05-12 |
2013-02-12 |
Affymax, Inc. |
Péptidos que se unen al receptor de eritropoyetina
|
WO2004101600A2
(fr)
|
2003-05-12 |
2004-11-25 |
Affymax, Inc. |
Nouveaux composes modifies par du poly(ethylene glycol) et leurs utilisations
|
US7074755B2
(en)
|
2003-05-17 |
2006-07-11 |
Centocor, Inc. |
Erythropoietin conjugate compounds with extended half-lives
|
JP2007537986A
(ja)
|
2003-05-30 |
2007-12-27 |
セントカー・インコーポレーテツド |
トランスグルタミナーゼを用いる新規なエリトロポエチン複合体の形成
|
US20050037390A1
(en)
|
2003-06-04 |
2005-02-17 |
Irm Llc, A Delaware Limited Liability Company |
Methods and compositions for modulating erythropoietin expression
|
US7579157B2
(en)
|
2003-07-10 |
2009-08-25 |
Hoffmann-La Roche Inc. |
Antibody selection method against IGF-IR
|
EA013614B1
(ru)
|
2003-07-15 |
2010-06-30 |
Амджен Инк. |
Изолированное антитело к фактору роста нервов (ngf) и способы его применения
|
TWI476206B
(zh)
|
2003-07-18 |
2015-03-11 |
Amgen Inc |
對肝細胞生長因子具專一性之結合劑
|
US20050019914A1
(en)
|
2003-07-24 |
2005-01-27 |
Aventis Pharma Deutschland Gmbh |
Perfusion process for producing erythropoietin
|
GB0317511D0
(en)
|
2003-07-25 |
2003-08-27 |
Biovex Ltd |
Viral vectors
|
JP2007512001A
(ja)
|
2003-08-28 |
2007-05-17 |
バイオレクシス ファーマシューティカル コーポレイション |
Epoミメティックペプチドおよび融合タンパク質
|
CN1882355A
(zh)
|
2003-09-09 |
2006-12-20 |
沃伦药品公司 |
保持内源性促红细胞生成素组织保护活性的长效促红细胞生成素
|
UA89481C2
(uk)
|
2003-09-30 |
2010-02-10 |
Центокор, Инк. |
Еритропоетинові міметичні шарнірно-серцевинні міметитіла людини, композиції, способи та застосування
|
WO2005081687A2
(fr)
|
2003-09-30 |
2005-09-09 |
Centocor, Inc. |
Mimeticorps de noyau-charniere humain, compositions, procedes et applications correspondantes
|
CN1886426A
(zh)
|
2003-11-07 |
2006-12-27 |
伊姆尼斯公司 |
结合白细胞介素-4受体的抗体
|
PE20050928A1
(es)
|
2003-11-21 |
2005-11-08 |
Schering Corp |
Combinaciones terapeuticas de anticuerpo anti-igfr1
|
US8633157B2
(en)
|
2003-11-24 |
2014-01-21 |
Novo Nordisk A/S |
Glycopegylated erythropoietin
|
US20070254834A1
(en)
|
2003-11-24 |
2007-11-01 |
Defrees Shawn |
Glycopegylated Erythropoietin
|
WO2005058967A2
(fr)
|
2003-12-16 |
2005-06-30 |
Pierre Fabre Medicament |
Nouveau recepteur hybride anti-insuline/igf-i ou recepteur hybride anti-insuline/igf-i et anticorps igf-ir et applications
|
EP1548031A1
(fr)
|
2003-12-22 |
2005-06-29 |
Dubai Genetics FZ-LLC |
Erythropoietin identique à la nature
|
US20050170457A1
(en)
|
2003-12-31 |
2005-08-04 |
Chadler Pool |
Novel recombinant proteins with N-terminal free thiol
|
AU2004309063B2
(en)
|
2003-12-31 |
2010-10-28 |
Merck Patent Gmbh |
Fc-erythropoietin fusion protein with improved pharmacokinetics
|
US7423139B2
(en)
|
2004-01-20 |
2008-09-09 |
Insight Biopharmaceuticals Ltd. |
High level expression of recombinant human erythropoietin having a modified 5′-UTR
|
WO2005070451A1
(fr)
|
2004-01-22 |
2005-08-04 |
Zafena Aktiebolag |
Composition pharmaceutique comprenant une erythropoietine non glycosylee
|
WO2005084711A1
(fr)
|
2004-03-02 |
2005-09-15 |
Chengdu Institute Of Biological Products |
Erythropoietine recombinante pegylee a activite in vivo
|
EP1758608A2
(fr)
|
2004-03-11 |
2007-03-07 |
Fresenius Kabi Deutschland GmbH |
Conjugues d'hydroxy-ethyl-amidon et d'erythropoietine
|
EP1740208A2
(fr)
|
2004-03-23 |
2007-01-10 |
Amgen, Inc |
Anticorps monoclonaux specifiques pour ox40l (cd134l) humain
|
US20050227289A1
(en)
|
2004-04-09 |
2005-10-13 |
Reilly Edward B |
Antibodies to erythropoietin receptor and uses thereof
|
US20080194475A1
(en)
|
2004-04-23 |
2008-08-14 |
Andrew Buchanan |
Erythropoietin Protein Variants
|
ES2325034T3
(es)
|
2004-07-07 |
2009-08-24 |
H. Lundbeck A/S |
Nueva epo carbamilada y metodo para su produccion.
|
FR2873699B1
(fr)
|
2004-07-29 |
2009-08-21 |
Pierre Fabre Medicament Sa |
Nouveaux anticorps anti igf ir rt leurs utilisations
|
WO2006029094A2
(fr)
|
2004-09-02 |
2006-03-16 |
Xencor, Inc. |
Derives d'erythropoietine a antigenicite modifiee
|
CA2586915A1
(fr)
|
2004-11-10 |
2006-05-18 |
Aplagen Gmbh |
Molecules favorisant l'hematopoiese
|
MY146381A
(en)
|
2004-12-22 |
2012-08-15 |
Amgen Inc |
Compositions and methods relating relating to anti-igf-1 receptor antibodies
|
CA2589860A1
(fr)
|
2005-01-24 |
2006-08-03 |
Amgen Inc. |
Anticorps anti-amyloide humanise
|
US7592429B2
(en)
|
2005-05-03 |
2009-09-22 |
Ucb Sa |
Sclerostin-binding antibody
|
BRPI0611984A2
(pt)
|
2005-06-17 |
2009-07-07 |
Imclone Systems Inc |
uso de anticorpos igf-ir para fabricação de um medicamento para tratar um tumor ósseo
|
WO2007000328A1
(fr)
|
2005-06-27 |
2007-01-04 |
Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa |
Anticorps se fixant à un épitope sur un récepteur de facteur de croissance insulinomimétique de type 1 et leurs utilisations
|
NO345593B1
(no)
|
2005-07-18 |
2021-05-03 |
Amgen Inc |
Humane anti-B7RP1 nøytraliserende antistoffer
|
FR2888850B1
(fr)
|
2005-07-22 |
2013-01-11 |
Pf Medicament |
Nouveaux anticorps anti-igf-ir et leurs applications
|
PE20071101A1
(es)
|
2005-08-31 |
2007-12-21 |
Amgen Inc |
Polipeptidos y anticuerpos
|
GB0603683D0
(en)
|
2006-02-23 |
2006-04-05 |
Novartis Ag |
Organic compounds
|
TWI395754B
(zh)
|
2006-04-24 |
2013-05-11 |
Amgen Inc |
人類化之c-kit抗體
|
RU2008150314A
(ru)
|
2006-05-19 |
2010-06-27 |
Гликофи, Инк. (Us) |
Композиции эритропоэтина
|
JP2008000287A
(ja)
*
|
2006-06-21 |
2008-01-10 |
Terumo Corp |
医療用具コーティング用摺動性組成物および摺動性被膜保有医療用具
|
CL2007002567A1
(es)
|
2006-09-08 |
2008-02-01 |
Amgen Inc |
Proteinas aisladas de enlace a activina a humana.
|
US20100040610A1
(en)
|
2006-11-07 |
2010-02-18 |
Ayesha Sitlani |
Antagonists of pcsk9
|
AU2007322265B2
(en)
|
2006-11-07 |
2013-06-20 |
Merck Sharp & Dohme Corp. |
Antagonists of PCSK9
|
CA2667869A1
(fr)
|
2006-11-07 |
2008-05-15 |
Merck & Co., Inc. |
Antagonistes de pcsk9
|
WO2008057457A2
(fr)
|
2006-11-07 |
2008-05-15 |
Merck & Co., Inc. |
Antagonistes de pcsk9
|
KR20090088950A
(ko)
|
2006-12-14 |
2009-08-20 |
쉐링 코포레이션 |
가공된 항-tslp 항체
|
EP2137218A2
(fr)
|
2007-04-13 |
2009-12-30 |
Novartis Ag |
Molécules et procédés de modulation de proprotéine convertase subtilisine/kexine de type 9 (pcsk9)
|
AU2008265128A1
(en)
|
2007-06-20 |
2008-12-24 |
Irm Llc |
Methods and compositions for treating allergic diseases
|
US7982016B2
(en)
|
2007-09-10 |
2011-07-19 |
Amgen Inc. |
Antigen binding proteins capable of binding thymic stromal lymphopoietin
|
CA2703712A1
(fr)
|
2007-10-26 |
2009-04-30 |
Joseph A. Hedrick |
Anti-pcsk9 et methodes de traitement de troubles du metabolisme lipidique et du cholesterol
|
AR070316A1
(es)
|
2008-02-07 |
2010-03-31 |
Merck & Co Inc |
Antagonistas de pcsk9 (proproteina subtilisina-kexina tipo 9)
|
AR070315A1
(es)
|
2008-02-07 |
2010-03-31 |
Merck & Co Inc |
Anticuerpos 1b20 antagonistas de pcsk9
|
TWI516501B
(zh)
|
2008-09-12 |
2016-01-11 |
禮納特神經系統科學公司 |
Pcsk9拮抗劑類
|
JO3672B1
(ar)
|
2008-12-15 |
2020-08-27 |
Regeneron Pharma |
أجسام مضادة بشرية عالية التفاعل الكيماوي بالنسبة لإنزيم سبتيليسين كنفرتيز بروبروتين / كيكسين نوع 9 (pcsk9).
|
JO3382B1
(ar)
|
2008-12-23 |
2019-03-13 |
Amgen Inc |
أجسام مضادة ترتبط مع مستقبل cgrp بشري
|
WO2011037791A1
(fr)
|
2009-09-25 |
2011-03-31 |
Merck Sharp & Dohme Corp. |
Antagonistes de pcsk9
|
CA3081980C
(fr)
*
|
2009-10-16 |
2022-10-18 |
Janssen Biotech, Inc. |
Dispositif d'administration de medicament active par la paume
|
AU2010313381A1
(en)
|
2009-10-30 |
2012-04-12 |
Merck Sharp & Dohme Corp. |
AX1 and AX189 PCSK9 antagonists and variants
|
WO2011053783A2
(fr)
|
2009-10-30 |
2011-05-05 |
Merck Sharp & Dohme Corp. |
Antagonistes et variants ax213 et ax132 pcsk9
|
AR079336A1
(es)
|
2009-12-11 |
2012-01-18 |
Irm Llc |
Antagonistas de la pro-proteina convertasa-subtilisina/quexina tipo 9 (pcsk9)
|
SA111320266B1
(ar)
|
2010-03-11 |
2015-06-21 |
رينات نيوروساينس كوربوريشن |
أجسام مضادة مع ارتباط مولد مضاد يعتمد على الأس الهيدروجيني
|
WO2012054438A1
(fr)
|
2010-10-22 |
2012-04-26 |
Schering Corporation |
Anti-pcsk9
|
US20120195910A1
(en)
|
2010-12-22 |
2012-08-02 |
Genentech, Inc. |
Anti-pcsk9 antibodies and methods of use
|
PE20140372A1
(es)
|
2011-01-28 |
2014-03-24 |
Sanofi Sa |
Composiciones farmaceuticas que comprenden anticuerpos humanos frente a pcsk9
|
BR112013020402A2
(pt)
|
2011-02-11 |
2018-09-25 |
Irm Llc |
antagonistas pcsk9
|
JOP20200043A1
(ar)
|
2011-05-10 |
2017-06-16 |
Amgen Inc |
طرق معالجة أو منع الاضطرابات المختصة بالكوليسترول
|
JP6207401B2
(ja)
*
|
2012-01-31 |
2017-10-04 |
テルモ株式会社 |
プレフィルドシリンジ用シリンジ
|
CA2878716C
(fr)
*
|
2012-07-11 |
2021-05-04 |
Unitract Syringe Pty Ltd |
Mecanismes d'insertion comprenant des conduites de fluide mises a l'air libre pour des pompes de distribution de medicaments
|
WO2014099984A1
(fr)
|
2012-12-20 |
2014-06-26 |
Amgen Inc. |
Agonistes du récepteur apj et leurs utilisations
|
AP2015008729A0
(en)
|
2013-03-14 |
2015-09-30 |
Amgen Inc |
Variants of tissue inhibitor of metalloproteinase type three (timp-3), compositions and methods
|
US20140274874A1
(en)
|
2013-03-14 |
2014-09-18 |
Amgen Inc. |
Variants of tissue inhibitor of metalloproteinase type three (timp-3), compositions and methods
|
US10258744B2
(en)
*
|
2013-04-05 |
2019-04-16 |
West Pharmaceutical Services, Inc. |
Pharmaceutical syringe piston
|
AU2014274061C1
(en)
*
|
2013-05-31 |
2019-06-13 |
Mannkind Corporation |
A fluid delivery device having an insertable prefilled cartridge
|
CA2949846C
(fr)
*
|
2014-06-03 |
2023-09-05 |
Amgen Inc. |
Dispositifs et procedes pour aider un utilisateur d'un dispositif d'administration de medicament
|
JP6348366B2
(ja)
*
|
2014-07-31 |
2018-06-27 |
住友ゴム工業株式会社 |
ガスケット
|
EP3188776B1
(fr)
*
|
2014-09-02 |
2018-07-04 |
Eli Lilly And Company |
Système de détection d'un piston dans un conteneur de fluide médicale
|
GB2532300B
(en)
*
|
2014-09-30 |
2018-09-19 |
Owen Mumford Ltd |
Injection devices
|
WO2016100781A1
(fr)
*
|
2014-12-19 |
2016-06-23 |
Amgen Inc. |
Dispositif d'administration de médicament doté d'un capteur de proximité
|
WO2017157396A1
(fr)
*
|
2016-03-13 |
2017-09-21 |
Tina Hetting Holding Aps |
Injecteur à force de détachement réduite
|
US10493207B2
(en)
|
2017-02-27 |
2019-12-03 |
W. L. Gore & Associates, Inc. |
Medical delivery devices having low lubricant syringe barrels
|